Canaccord Genuity Analysts Give Perrigo (PRGO) a $105.00 Price Target

Canaccord Genuity set a $105.00 target price on Perrigo (NYSE:PRGO) in a research report released on Monday morning. The brokerage currently has a buy rating on the stock.

PRGO has been the topic of a number of other research reports. Leerink Swann assumed coverage on shares of Perrigo in a research note on Tuesday, January 2nd. They set a market perform rating and a $90.00 target price on the stock. Oppenheimer set a $98.00 target price on shares of Perrigo and gave the company a buy rating in a research note on Monday, March 5th. Cantor Fitzgerald set a $107.00 price target on shares of Perrigo and gave the stock a buy rating in a research note on Friday, January 19th. JPMorgan Chase reiterated a neutral rating and issued a $83.00 price target (up previously from $82.00) on shares of Perrigo in a research note on Monday, March 5th. Finally, Berenberg Bank initiated coverage on shares of Perrigo in a research note on Thursday, February 1st. They issued a buy rating and a $117.00 price target on the stock. One research analyst has rated the stock with a sell rating, ten have given a hold rating and nine have issued a buy rating to the stock. The company currently has an average rating of Hold and a consensus price target of $91.88.

PRGO opened at $81.94 on Monday. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.40 and a current ratio of 1.96. Perrigo has a fifty-two week low of $63.68 and a fifty-two week high of $95.93. The firm has a market cap of $11,673.70, a P/E ratio of 16.62, a PEG ratio of 2.06 and a beta of 0.76.



Perrigo (NYSE:PRGO) last released its earnings results on Thursday, March 1st. The company reported $1.28 earnings per share for the quarter, beating analysts’ consensus estimates of $1.25 by $0.03. Perrigo had a net margin of 2.42% and a return on equity of 11.54%. The company had revenue of $1.28 billion for the quarter, compared to analysts’ expectations of $1.26 billion. During the same quarter in the previous year, the company earned $1.24 EPS. Perrigo’s revenue for the quarter was down 3.6% on a year-over-year basis. equities analysts expect that Perrigo will post 5.23 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 20th. Stockholders of record on Friday, March 2nd were issued a $0.19 dividend. The ex-dividend date was Thursday, March 1st. This is an increase from Perrigo’s previous quarterly dividend of $0.16. This represents a $0.76 dividend on an annualized basis and a dividend yield of 0.93%. Perrigo’s payout ratio is 15.42%.

In other Perrigo news, CEO Uwe Roehrhoff bought 7,500 shares of Perrigo stock in a transaction dated Monday, March 5th. The shares were purchased at an average cost of $81.85 per share, for a total transaction of $613,875.00. Following the acquisition, the chief executive officer now directly owns 4,900 shares in the company, valued at approximately $401,065. The acquisition was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders own 6.90% of the company’s stock.

Several institutional investors have recently bought and sold shares of PRGO. Dupont Capital Management Corp bought a new stake in shares of Perrigo in the 4th quarter worth about $104,000. ARP Americas LP bought a new stake in shares of Perrigo in the 4th quarter worth about $212,000. Quantitative Systematic Strategies LLC bought a new stake in shares of Perrigo in the 4th quarter worth about $213,000. V Wealth Management LLC bought a new stake in shares of Perrigo in the 4th quarter worth about $214,000. Finally, Investors Research Corp bought a new stake in shares of Perrigo in the 4th quarter worth about $214,000. Hedge funds and other institutional investors own 79.11% of the company’s stock.

WARNING: “Canaccord Genuity Analysts Give Perrigo (PRGO) a $105.00 Price Target” was originally reported by Dakota Financial News and is the property of of Dakota Financial News. If you are reading this news story on another domain, it was illegally stolen and republished in violation of United States & international copyright and trademark legislation. The original version of this news story can be viewed at https://dakotafinancialnews.com/2018/04/12/canaccord-genuity-analysts-give-perrigo-prgo-a-105-00-price-target.html.

About Perrigo

Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter (OTC) healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products worldwide. The company operates through Consumer Healthcare Americas, Consumer Healthcare International, and Prescription Pharmaceuticals segments.

Analyst Recommendations for Perrigo (NYSE:PRGO)

Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply